Reliable and sensitive determination of dutasteride in human plasma by liquid chromatography-tandem mass spectrometry

被引:5
作者
Contractor, Pritesh [1 ,2 ]
Kurani, Hemal [1 ]
Guttikar, Swati [1 ]
Shrivastav, Pranav S. [3 ]
机构
[1] Veeda Clin Res, Bioanalyt Dept, Ahmadabad 387810, Gujarat, India
[2] Kadi Univ, Dept Chem, Gandhinagar 328015, India
[3] Gujarat Univ, Sch Sci, Dept Chem, Ahmadabad 380009, Gujarat, India
关键词
dutasteride; dutasteride-13C6; liquid-liquid extraction; LC-MS/MS; human plasma; bioequivalence study; PHARMACEUTICAL DOSAGE FORMS; LC-MS-MS; PROSTATE-CANCER; TAMSULOSIN; ALFUZOSIN; HYDROCHLORIDE; INHIBITORS; ASSAY;
D O I
10.1002/bmc.2923
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An accurate and precise method was developed and validated using LC-MS/MS to quantify dutasteride in human plasma. The analyte and dutasteride-13C6 as internal standard (IS) were extracted from 300 mu L plasma volume using methyl tert-butyl ether-n-hexane (80:20, v/v). Chromatographic analysis was performed on a Gemini C-18 (150 x 4.6 mm, 5 mm) column using acetonitrile-5 mM ammonium formate, pH adjusted to 4.0 with formic acid (85: 15, v/v) as the mobile phase. Tandem mass spectrometry in positive ionization mode was used to quantify dutasteride by multiple reaction monitoring. The entire data processing was done using Watson LIMS (TM) software, which provided excellent data integrity and high throughput with improved operational efficiency. The calibration curve was linear in the range of 0.1-25 ng/mL, with intra-and inter-batch values for accuracy and precision (coefficient of variation) ranging from 95.8 to 104.0 and from 0.7 to 5.3%, respectively. The mean overall recovery across quality controls was >= 95% for the analyte and IS, while the interference of matrix expressed as IS-normalized matrix factors ranged from 1.01 to 1.02. The method was successfully applied to support a bioequivalence study of 0.5 mg dutasteride capsules in 24 healthy subjects. Assay reproducibility was demonstrated by reanalysis of 103 incurred samples. Copyright (C) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:1168 / 1176
页数:9
相关论文
共 19 条
[1]   Simultaneous determination of tamsulosin and dutasteride in human plasma by LC-MS-MS [J].
Agarwal, Sangita ;
Gowda, K. Veeran ;
Sarkar, Amlan Kanti ;
Ghosh, Debotri ;
Bhaumik, Uttam ;
Chattaraj, Tapas Kumar ;
Pal, Tapan Kumar .
CHROMATOGRAPHIA, 2008, 67 (11-12) :893-903
[2]   Role of 5α-Reductase Inhibitors in Prostate Cancer Prevention and Treatment [J].
Azzouni, Faris ;
Mohler, James .
UROLOGY, 2012, 79 (06) :1197-1205
[3]   Stability-Indicating TLC Method for the Determination of Dutasteride in Pharmaceutical Dosage Forms [J].
Choudhari, Vishnu P. ;
Nikalje, Anna Pratima .
CHROMATOGRAPHIA, 2009, 70 (1-2) :309-313
[4]   Validated HPTLC Method for Simultaneous Analysis of Alfuzosin Hydrochloride and Dutasteride in a Pharmaceutical Dosage Form [J].
Deshmukh, Shivprasad S. ;
Musale, Vaishali V. ;
Bhusari, Vidhya K. ;
Dhaneshwar, Sunil R. .
JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2011, 24 (03) :218-221
[5]  
Elzayat EA, 2008, CURRENT PROSTATE REP, V6, P74
[6]  
FDA, 2001, GUID IND BION METH V
[7]  
FDA, 1996, GUID IND ICH E6 GOOD
[8]   Rapid and Sensitive LC-MS-MS Method for the Simultaneous Estimation of Alfuzosin and Dutasteride in Human Plasma [J].
Gomes, Noel A. ;
Pudage, Ashutosh ;
Joshi, Santosh S. ;
Vaidya, Vikas V. ;
Parekh, Sagar A. ;
Tamhankar, Amod V. .
CHROMATOGRAPHIA, 2009, 69 (1-2) :9-18
[9]   Role of 5 alpha-reductase inhibitors in the management of prostate cancer [J].
Hudak, Steven J. ;
Hernandez, Javier ;
Thompson, Ian M. .
CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) :425-431
[10]   Determination of dutasteride by LC: Validation and application of the method [J].
Kamat, Sudhir S. ;
Choudhari, Vishal B. ;
Vele, Vinayak T. ;
Prabhune, Swarup S. .
CHROMATOGRAPHIA, 2008, 67 (11-12) :911-916